Literature DB >> 20602209

Production of antipeptide antibodies.

Bao-Shiang Lee1, Jin-Sheng Huang, G D Lasanthi P Jayathilaka, Syed S Lateef, Shalini Gupta.   

Abstract

Peptides (8-20 residues) are as effective as proteins in raising antibodies, both polyclonal and monoclonal with a titer above 20,000 easily achievable. A successful antipeptide antibody production depends on several factors such as peptide sequence selection, peptide synthesis, peptide-carrier protein conjugation, the choice of the host animal, and antibody purification. Peptide sequence selection is likely the most difficult and critical step in the development of antipeptide antibodies. Although the format for designing peptide antigens is not precise, several guidelines can help maximize the likelihood of producing high-quality antipeptide antibodies. Typically, 5-20 mg of peptide is enough for raising an antibody, for preparing a peptide affinity column, and for antibody titer determination using an enzyme-linked immunosorbent assay (ELISA). Usually, it takes 3 months to raise a polyclonal antipeptide antibody from a rabbit that yields ~90 mL of serum which translates into approximately 8-10 mg of the specific antibody after peptide affinity purification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602209     DOI: 10.1007/978-1-60761-783-9_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy.

Authors:  Heng-Huan Lee; Ying-Nai Wang; Weiya Xia; Chia-Hung Chen; Kun-Ming Rau; Leiguang Ye; Yongkun Wei; Chao-Kai Chou; Shao-Chun Wang; Meisi Yan; Chih-Yen Tu; Te-Chun Hsia; Shu-Fen Chiang; K S Clifford Chao; Ignacio I Wistuba; Jennifer L Hsu; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2019-07-18       Impact factor: 31.743

2.  Confetti: a multiprotease map of the HeLa proteome for comprehensive proteomics.

Authors:  Xiaofeng Guo; David C Trudgian; Andrew Lemoff; Sivaramakrishna Yadavalli; Hamid Mirzaei
Journal:  Mol Cell Proteomics       Date:  2014-04-02       Impact factor: 5.911

Review 3.  Antidotes, antibody-mediated immunity and the future of pharmaceutical product development.

Authors:  Salvador Eugenio C Caoili
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

Review 4.  The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis.

Authors:  Ying-Nai Wang; Heng-Huan Lee; Jennifer L Hsu; Dihua Yu; Mien-Chie Hung
Journal:  J Biomed Sci       Date:  2020-07-03       Impact factor: 8.410

Review 5.  Peptides, Antibodies, Peptide Antibodies and More.

Authors:  Nicole Trier; Paul Hansen; Gunnar Houen
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

6.  Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus.

Authors:  Shikun Ge; Rao Wu; Tingting Zhou; Xiang Liu; Jin Zhu; Xiaoying Zhang
Journal:  AMB Express       Date:  2022-02-12       Impact factor: 3.298

7.  Genomic and Phenotypic Characterization of Cutibacterium acnes Bacteriophages Isolated from Acne Patients.

Authors:  Shukho Kim; Hyesoon Song; Jong Sook Jin; Weon Ju Lee; Jungmin Kim
Journal:  Antibiotics (Basel)       Date:  2022-08-02

8.  Development of gold Immunochromatographic assay strip based on specific polyclonal antibodies against capsid protein for rapid detection of porcine circovirus 2 in Zhejiang province, China.

Authors:  Haojie Ding; Yu Shen; Yafan Gao; Songrui Wu; ChengZuo Xie; Hao Sun; Hongli Zhang; Hongchao Sun; Ying Shan; Jianzu Ding; Bin Zheng; Shaohong Lu; Xunhui Zhuo
Journal:  BMC Vet Res       Date:  2022-10-18       Impact factor: 2.792

9.  Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis.

Authors:  Junying Xu; Xuejing Yang; Yong Mao; Jie Mei; Huiyu Wang; Junli Ding; Dong Hua
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.